Previous Article | Next Article ![]()
Mol. Cell. Biol., 03 1995, 1203-1209, Vol 15, No. 3
J Horiuchi, N Silverman, GA Marcus and L Guarente
Mutations in yeast ADA2, ADA3, and GCN5 weaken the activation potential of
a subset of acidic activation domains. In this report, we show that their
gene products form a heterotrimeric complex in vitro, with ADA2 as the
linchpin holding ADA3 and GCN5 together. Further, activation by LexA-ADA3
fusions in vivo are regulated by the levels of ADA2. Combined with a prior
observation that LexA-ADA2 fusions are regulated by the levels of ADA3 (N.
Silverman, J. Agapite, and L. Guarente, Proc. Natl. Acad. Sci. USA
91:11665-11668, 1994), this finding suggests that these proteins also form
a complex in cells. ADA3 can be separated into two nonoverlapping domains,
an amino-terminal domain and a carboxyl- terminal domain, which do not
separately complement the slow-growth phenotype or transcriptional defect
of a delta ada3 strain but together supply full complementation. The
carboxyl-terminal domain of ADA3 alone suffices for heterotrimeric complex
formation in vitro and activation of LexA-ADA2 in vivo. We present a model
depicting the ADA complex as a coactivator in which the ADA3 amino-terminal
domain mediates an interaction between activation domains and the ADA
complex.
Copyright © 1995, American Society for Microbiology
ADA3, a putative transcriptional adaptor, consists of two separable domains and interacts with ADA2 and GCN5 in a trimeric complex
Department of Biology, Massachusetts Institute of Technology, Cambridge 02139.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|